Skip to Main Content

Yale Pediatric Pulmonology Fellowship


Welcome to the Yale Pediatric Pulmonology Fellowship Program website! Our program was accredited in 1991 and over 30 fellows have trained in our program. We participate in the match and have one new fellow per year. Our fellowship training program is 3 years long with the option (with application and matching) to do an additional year of Sleep Medicine training.

All incoming trainees must have successfully completed a 3-year pediatrics residency program to be eligible for our fellowship program. Additionally, the residency must be an ACGME accredited program to be eligible for the American Board of Pediatrics pulmonary board examination. Fellows must be U.S. citizens or hold a J-1 or H-1B Visa to be eligible. Foreign trained physicians must have successfully completed all parts of the ECFMG examination prior to their start date.

The goal of the Pediatric Pulmonology Fellowship at Yale New Haven Children's Hospital is to provide trainees with the most complete, up-to-date educational experience possible in the field of Pediatric Pulmonary Medicine. We aim to create specialist physicians who are adept at all areas of activity of an academic physician including clinical care, research, and teaching. In addition to offering outstanding clinical training with a diverse population of patients and a wide array of respiratory problems, the fellowship program offers four distinct pathways for scholarly activities: Clinician Educator (medical education), Quality Improvement, Global Health, and Investigation (clinical, translational, or basic science research). These pathways allow fellows to pursue their career interests and hone their scholarly activity skills in a particular area during their training. Fellows are encouraged to seek mentorship from across many disciplines that Yale has to offer. Additionally, our fellows are taught by a diverse faculty with expertise spanning the breadth of pulmonary and sleep medicine. If you are looking for a training program in an academically focused environment with opportunities to pursue your passion for pulmonary medicine, Yale is for you! Thank you for your interest in the fellowship training program at Yale Pediatrics.

Scholarly Pathways

Yale offers all fellows four unique scholarly pathways to guide professional development throughout the years of training.

The tracks include:

  1. Investigation (clinical, translational, and laboratory-based research)
  2. Quality Improvement and Patient Safety
  3. Medical Education
  4. Global Health
Although scholarly activities begin during the first year, most fellows will enroll in a pathway in their second year of fellowship training. Fellows are permitted to enroll in more than one pathway if their scholarly activities are relevant (for example, combining global health with quality improvement/patient safety, medical education, or investigation). Fellows should work with their mentors to select the pathway and activities that will be most beneficial when considering their individual career goals and aspirations.

Clinical Experience

Our fellows acquire clinical experience throughout their training. Our goal is to balance clinical training with scholarly activities throughout the first 2 years, and time during the third year will be apportioned according to the fellow’s career interest. The clinical time is spent on the inpatient and ambulatory service learning various aspects of pediatric pulmonary clinical practice. During the inpatient rotations, fellows participate in the diagnosis and management of patients on the pediatric inpatient service, medical subspecialty units such as the liver and bone marrow transplant units, and in the pediatric, neonatal, and cardiac intensive care units. Fellows gain experience in managing various pulmonary emergencies and complicated pulmonary disorders. They receive training in many procedures including diagnostic and therapeutic bronchoscopy, pulmonary function testing, cardiopulmonary exercise testing and interpreting sleep studies. Fellows participate in a half-day continuity clinic throughout all 3 years of training and rotate through subspecialty clinics such as general pulmonary, cystic fibrosis, sleep, asthma, bronchopulmonary dysplasia, technology dependent, neuromuscular diseases, and aerodigestive clinics. This clinical training allows the fellows to gain experience and competency in managing acute and chronic pediatric pulmonary problems.

Overview of the Clinical Training Program by Year

Year 1

  • 17-19 weeks - Inpatient Pediatric Pulmonary Service
  • 17-19 weeks - Research
  • 4-6 weeks - Pulmonary/Allergy/Immunology/Sleep Clinics
  • 4 weeks - Elective
  • 4 weeks - Vacation

Year 2

  • 10-12 weeks - Inpatient Pediatric Pulmonology Service
  • 24-30 weeks - Research
  • 4 weeks - Pulmonary/Allergy/Immunology/Sleep Clinics
  • 2-4 weeks - Elective
  • 4 weeks - Vacation

Year 3

  • 8-12 weeks - Inpatient Pediatric Pulmonology Service
  • 24-30 weeks - Research
  • 2 weeks - Teaching Fellow
  • 2 weeks - Fellow as Attending and Pulmonary/Allergy/Immunology/Sleep Clinics
  • 2-4 weeks- Elective
  • 4 weeks - Vacation

Research Experience

Yale University is well-known for its cutting-edge research. We believe that scholarship and the acquisition of high-quality research skills during fellowship are fundamental to the development of leadership, teaching skills, and critical thinking. Fellows may participate in scholarly activities including bioethics, medical education, global health, public health, health equity, quality improvement, public policy as well as clinical, translational, or basic science research. We provide opportunities for fellows to conduct research throughout Yale University. We have an individualized approach to the selection of the scholarly project and a strong track record of mentorship.

Each fellow has a Scholarship Oversight Committee, which meets at least twice a year to review and support the research progress. The Yale Pediatric Fellows Seminar and Pulmonology Conference provide venues for the fellows to present their work. Fellows are encouraged to present their research at regional, national, and international conferences, such as the American Thoracic Society International Conference, the North American Cystic Fibrosis Conference, and annual CHEST meeting.

Fellow Publications

Our fellows are extremely productive and have an excellent track record. They have published in peer-reviewed journals and presented their research at national meetings.

  • Sendon CS, Cowles RA, Worhunsky DJ, Hodson D, Morotti R, Bazzy-Asaad A, Esquibies AE. Pediatric unilobar resection in primary ciliary dyskinesia. Minerva Pediatr. 2020 Jul 29. doi: 10.23736/S0026-4946.20.05802-8. Epub ahead of print. PMID: 32731729.
  • Sendon C, Esquibies AE. ITGB (Integrin subunit beta) 3 mutation involved in pulmonary hemorrhage and osteopetrosis. Respir Med Case Rep. 2019 Feb 16;26:270-272. doi: 10.1016/j.rmcr.2019.02.011. PMID: 30828542; PMCID: PMC6383188.
  • Sharma L, Rebaza A, Dela Cruz CS. When "B" becomes "A": the emerging threat of influenza B virus. Eur Respir J. 2019 Aug 15;54(2):1901325. doi: 10.1183/13993003.01325-2019. PMID: 31416813.
  • Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med. 2020 Mar;8(3):e13. doi: 10.1016/S2213-2600(20)30066-7. Epub 2020 Feb 13. PMID: 32061333; PMCID: PMC7128440.
  • Walz L, Cohen AJ, Rebaza AP, Vanchieri J, Slade MD, Dela Cruz CS, Sharma L. JAK-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis. Res Sq [Preprint]. 2020 Aug doi: 10.21203/ Update in: BMC Infect Dis. 2021 Jan 11;21(1):47. PMID: 32869016; PMCID: PMC7457585.
  • Cherian C, Buta E, Simon P, Gueorguieva R, Krishnan-Sarin S. Association of Vaping and Respiratory Health among Youth in the Population Assessment of Tobacco and Health (PATH) Study Wave 3. Int J Environ Res Public Health. 2021 Aug 3;18(15):8208. doi: 10.3390/ijerph18158208. PMID: 34360499; PMCID: PMC8346152.
  • Kesebir D, Vazquez M, Weibel C, Shapiro ED, Ferguson D, Landry ML, Kahn JS. Human bocavirus infection in young children in the United States: molecular epidemiological profile and clinical characteristics of a newly emerging respiratory virus. J Infect Dis. 2006 Nov 1;194(9):1276-82.
  • Kahn JS, Kesebir D, Cotmore SF, D'Abramo A Jr, Cosby C, Weibel C, Tattersall P. Seroepidemiology of human bocavirus defined using recombinant virus-like particles. J Infect Dis. 2008 Jul 1;198(1):41-50.
  • Esquibies AE, Zambrano E, Ziai J, Kesebir D, Touloukian RJ, Egan ME, Reyes-Múgica M, Bazzy-Asaad A. Pulmonary squamous cell carcinoma associated with repaired congenital tracheoesophageal fistula and esophageal atresia. Pediatr Pulmonol. 2010 Feb;45(2):202-4.
  • Kevill KA, Bhandari V, Kettunen M, Leng L, Fan J, Mizue Y, Dzuira JD, Reyes-Mugica M, McDonald CL, Baugh JA, O'Connor CL, Aghai ZH, Donnelly SC, Bazzy-Asaad A, Bucala RJ. A role for macrophage migration inhibitory factor in the neonatal respiratory distress syndrome. J Immunol. 2008 Jan 1;180(1):601-8.
  • Dokmeci E, Herrick CA. The immune system and atopic dermatitis. Semin Cutan Med Surg. 2008 Jun;27(2):138-43.
  • Dokmeci E, Xu L, Robinson E, Golubets K, Bottomly K, Herrick CA.EBI3 deficiency leads to diminished T helper type 1 and increased T helper type 2 mediated airway inflammation. Immunology. 2011 Apr;132(4):559-66.
  • Nakra N, Bhargava S, Dzuira J, Caprio S, Bazzy-Asaad A. Sleep-disordered breathing in children with metabolic syndrome: the role of leptin and sympathetic nervous system activity and the effect of continuous positive airway pressure. Pediatrics. 2008 Sep;122(3):e634-42.
  • Shenoy A, Esquibies AE, Dunbar N, Dishop M, Reyes-Mugica M, Langston C, Deladoëy J, Abu-Khudir R, Carpenter T, Bazzy-Asaad A. A Novel Presentation of Diffuse Lung Disease Secondary to Congenital Hypothyroidism. J Pediatr 155:593-595, 2009.
  • Shenoy A, Kopic S, Murek M, Caputo C, Geibel JP, Egan ME. Calcium-modulated chloride pathways contribute to chloride flux in murine cystic fibrosis-affected macrophages. Pediatr Res. 2011 Nov;70(5):447-52.
  • Bruscia EM, Zhang PX, Satoh A, Caputo C, Medzhitov R, Shenoy A, Egan ME, Krause DS. Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis. J Immunol. 2011 Jun 15;186(12):6990-8.
  • Ishak, M., Zambrano, E. V., Bazzy-Asaad, A. and Esquibies, A. E. (2011), Unusual pulmonary findings in mucolipidosis II. Pediatr Pulmonol. 2012 Jul;47(7):719-21.
  • Navas-Nazario A., Li FY., Northrup V., Weiss P., Cole DEC., Carpenter TO., Bazzy-Asaad A. Effect of Vitamin D Binding Protein (DBP) Genotype on the Development of Asthma in Children, Ann Allergy Asthma Immunol. 2014 Jun;112(6):519-24.
  • Patel A., Weismann C., Weiss P., Russell K., Bazzy-Asaad A., Kadan-Lottick N. The Association Between Right Ventricular Dysfunction and Restrictive Lung Disease in Childhood Cancer Survivors as Measured by Quantitative Echocardiography, Pediatr Blood Cancer. 2014 Aug 17. doi: 10.1002/pbc.25157. [Epub ahead of print]

How to Apply

We participate in the Pediatric Respiratory Fellowship Match of the NRMP (National Resident Match Program).
All interested applicants should submit an application through ERAS (Electronic Residency Application Service).

Documents Required for Application

  • Three letters of recommendation forwarded from Faculty members, including Departmental Chairpersons or Chiefs of Service
  • Up-to-date Curriculum Vitae with any medical or scientific publications listed
  • Copy of Medical School Diploma
  • Copy of ECFMG certificate (if applicable)
  • Personal statement
  • Completion of an ACGME accredited pediatrics residency is required

All applicants that are competitive for positions will have a personal interview scheduled between August/September and October. Yale University School of Medicine is an Equal Opportunity Employer.

Address inquiries to: Phyllis Miller, Pediatric Fellowship Coordinator